Rab2A modulates liver fibroblast growth factor 21 (FGF21) expression and systemic metabolism via apolipoprotein B–CREBH signaling
Journal of Biological Chemistry · 2026-01 · 302 (1) · 110977
DOI: 10.1016/j.jbc.2025.110977 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-01. Verfasst von Zi-Yue Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, School o…. Hauptthemen laut MEDLINE: Liver, rab2 GTP-Binding Protein, Fibroblast Growth Factors, Golgi Apparatus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Fibroblast growth factor 21 (FGF21) is a hepatokine that regulates systemic metabolism. Here, we delineate a novel regulatory pathway for FGF21 orchestrated by the small GTPase Rab2A. Our previous findings demonstrated that liver-specific deficiency of Rab2A impairs very low-density lipoprotein lipidation and promotes apolipoprotein B (APOB) accumulation. We now show that accumulated APOB drives the cleavage and activation of cAMP-responsive element-binding protein H (CREBH), a key hepatic transcription factor for FGF21 expression. Mechanistically, hepatic Rab2A inhibition protected mice from high-fat diet-induced obesity and was associated with markedly elevated circulating FGF21, the phenotype largely rescued by adenovirus-mediated knockdown of either CREBH or APOB. Collectively, we define a Rab2A-APOB-CREBH axis that is potentially essential for the hepatic regulation of FGF21.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, School of Medicine, Nanjing University, Nanjing, China.
- Institute of Trauma and Metabolism, Zhengzhou Central Hospital, Zhengzhou University, Zhengzhou, China.
- State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, School of Medicine, Nanjing University, Nanjing, China. Electronic address: ch…
- State Key Laboratory of Metabolic Dysregulation & the Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory for Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou Central Hospital, Zhengzh…
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
Zitieren
APA
Chen, Z. Y., Xu, M., Chen, S., & Chen, L. (2026). Rab2A modulates liver fibroblast growth factor 21 (FGF21) expression and systemic metabolism via apolipoprotein B–CREBH signaling. Journal of Biological Chemistry, 302(1), 110977. https://doi.org/10.1016/j.jbc.2025.110977
Vancouver
Chen ZY, Xu M, Chen S, Chen L. Rab2A modulates liver fibroblast growth factor 21 (FGF21) expression and systemic metabolism via apolipoprotein B–CREBH signaling. Journal of Biological Chemistry. 2026;302(1):110977. doi:10.1016/j.jbc.2025.110977
BibTeX
@article{Chen2026,
author = {Chen, Zi-Yue and Xu, Min and Chen, Shuai and Chen, Liang},
title = {Rab2A modulates liver fibroblast growth factor 21 (FGF21) expression and systemic metabolism via apolipoprotein B–CREBH signaling},
journal = {Journal of Biological Chemistry},
year = {2026},
volume = {302},
number = {1},
pages = {110977},
doi = {10.1016/j.jbc.2025.110977}
}
EUVIMED